GI OnDEMAND Announces Partnership with Trellus Health

GI OnDEMAND®, gastroenterology’s leading multidisciplinary virtual integrated care platform today announced a partnership with Trellus Health, the creator of the leading digitally delivered Inflammatory Bowel Disease (IBD) resilience driven self-management solution for all patients with IBD.

GI OnDEMAND, a joint venture between the American College of Gastroenterology and Gastro Girl, Inc., will now offer access to the Trellus scientifically validated resilience training and self-management programs, to all GI OnDEMAND and ACG members nationwide. Members will now be able to offer their patients the much-needed holistic wrap around services to help support providers and patients in between office visits wherever and whenever they need it. Trellus coordinates and delivers personalized behavioral, emotional, and nutritional support to patients with IBD via digital solutions and remote access to an expert resilience training team of coaches, dietitians, and nurse educators all while leaving the clinical care to their health care providers. The suite of Trellus programs empowers patients to live healthier and more fulfilling lives, effectively self-manage their condition, adhere to treatment plans, and engage in effective interactions with their health care team.

Marla Dubinsky, MD, CEO and Co-Founder Trellus Health said:

“Trellus represents a paradigm shift in the way that we support patients with Crohn’s disease and ulcerative colitis incorporating a whole-person methodology that has, to date, been missing from the collective approach. Trellus reflects the learnings, frustrations and passion that has resulted from the nearly 25 years both Dr Laurie Keefer and I have dedicated to improving the lives of individuals with IBD. At Trellus we hope to empower patients to master the art of self-management, manage their IBD with confidence, and improve health outcomes at a significantly lower cost.”

“GI OnDEMAND expands a provider’s ability to deliver a first in class patient self-management solution for IBD. All patients have access to a digitally delivered, resilience-based, self-management training program developed and validated at Mount Sinai (NY) to help your patients take charge of their health needs, access behavioral and emotional support in between office visits and experience better outcomes,” said William Chey, MD, FACG, of the University of Michigan and Senior Director, Nutrition and Behavioral Health Services, GI OnDEMAND. “This is exactly what our GI patients need.”

“Our partnership with Trellus Health reflects a mutual a passion for taking a multidisciplinary approach to patient care and an unwavering mission to make digestive health expertise, resources and support accessible to everyone,” said Jacqueline Gaulin, Founder, Chief Strategy Officer, Gastro Girl/GI OnDEMAND. “We look forward to working together with the Trellus team to further expand the awareness and reach of the Trellus IBD program so all patients with IBD have access to this personalized and evidence-based program that gives them the tools and the team to better manage their health and live well physically, emotionally and socially.”

Learn More About the GI OnDEMAND and Trellus Health Partnership at ACG 2022

Visit GI OnDEMAND Booth #725 at the Charlotte Convention Center during ACG’s Annual Scientific Meeting October 23-26 in Charlotte, NC

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”
Exit mobile version